Pyrrolo-1,5-Benzoxazepines Induce Apoptosis in Chronic Myeloid Leukemia (CML) Cells by Bypassing the Apoptotic Suppressor BCR-ABL by Margaret M. Mc Gee, Giuseppe Campiani, Anna Ramunno, Caterina Fattorusso, Vito Nacci, Mark Lawler, D. Clive Williams, Daniela M. Zisterer

Get full text

Cancer inequalities in the United Kingdom and the data used to measure them: a scoping review by Sarah Underwood, Emre Oguzman, Judith Cole, Raphael Goldacre, Nileema Patel, David Davies, Claire Friedemann-Smith, F Lucy Wright, Ben Lacey, Brian D. Nicholson, Sasha Shepperd, Mark Lawler, Eva J.A. Morris

Get full text

Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths... by Richard D Neal, Amitava Banerjee, Deenan Pillay, Vahe Nafilyan, Clare Turnbull, Harry Hemingway, Bryan Williams, Mark Lawler, Monica Jones, Kathy Pritchard-Jones, Mahdad Noursadeghi, Richard Sullivan, Graham R Foster, Ben Humberstone, Alvina G Lai, Laura Pasea, Geoff Hall, Wai Hoong Chang, Michail Katsoulis, David Linch, Derralynn Hughes, Martin D Forster, Natalie K Fitzpatrick, Kathryn Boyd, Tariq Enver, Matt Cooper, Charlie Davie

Get full text

A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers by Peter Gallagher, Christian Rolfo, Elena Elez, Julien Taieb, Jennifer Houlden, Linda Collins, Corran Roberts, Thierry André, Mark Lawler, Federica Di Nicolantonio, Margaret Grayson, Ruth Boyd, Vlad Popovici, Alberto Bardelli, Robbie Carson, Hajrah Khawaja, Pierre Laurent-Puig, Manuel Salto-Tellez, Bryan T. Hennessy, Tim S. Maughan, Josep Tabernero, Richard Adams, Robert Jones, Marc Peeters, Mark R. Middleton, Richard H. Wilson, Sandra Van Schaeybroeck, on behalf of the MErCuRIC Trial Consortium

Get full text

A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC) by Francesca Aroldi, Elena Elez, Thierry André, Geraldine Perkins, Hans Prenen, Vlad Popovici, Peter Gallagher, Jennifer Houlden, Linda Collins, Corran Roberts, Christian Rolfo, Federica Di Nicolantonio, Margaret Grayson, Ruth Boyd, Karolien Bettens, Jurgen Delfavero, Victoria Coyle, Mark Lawler, Hajrah Khawaja, Pierre Laurent-Puig, Manuel Salto-Tellez, Tim S. Maughan, Josep Tabernero, Richard Adams, Robert Jones, Bryan T. Hennessy, Alberto Bardelli, Marc Peeters, Mark R. Middleton, Richard H. Wilson, Sandra Van Schaeybroeck, on behalf of the MErCuRIC Trial Consortium

Get full text

Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012–2017: an ICBP population-based study by Andriana Barisic, Samantha Harrison, David Baldwin, Sean McPhail, Georgios Lyratzopoulos, Matthew E Barclay, Laura Downie, Richard Walton, Bin Zhang, Mark Lawler, John Butler, Oliver Bucher, Haiyan Wang, Bjorn Møller, Lorraine Shack, Ryan R Woods, Nathalie Saint-Jacques, Nicola Creighton, David S Morrison, Luc te Marvelde, Dyfed W Huws, Catherine S Thomson, Grace Musto, Shane A Johnson, Ruth Swann, Riaz Alvi, David A Cameron, Christian J Finley, Damien B Bennett, Cheryl A Denny, Ron A Dewar, David W Donnelly, Jeff J Dowden, Norah Finn, Steven Habbous, S Eshwar Kumar, Leon May, Carol A McClure, Yngvar Nilssen, Sabuj Sarker, Xiaoyi Tian, Robert JS Thomas, Tommy Hon Ting Wong, Hui You, Paul A Dawkins, Sharon Fung, Kathryn E Green, Elba Gomez Navas, Jihee Han, David T Ransom

Get full text